167 related articles for article (PubMed ID: 36074931)
1. The Mediation Role of Thyrotropin Receptor Antibody in the Relationship Between Age and Severity of Hyperthyroidism in Graves' Disease.
Suzuki N; Inoue K; Yoshimura R; Kinoshita A; Suzuki A; Fukushita M; Matsumoto M; Yoshihara A; Watanabe N; Noh JY; Katoh R; Sugino K; Ito K
Thyroid; 2022 Oct; 32(10):1243-1248. PubMed ID: 36074931
[No Abstract] [Full Text] [Related]
2. The association of TSH-receptor antibody with the clinical and laboratory parameters in patients with newly diagnosed Graves' hyperthyroidism: experience from a tertiary referral center including a large number of patients with TSH-receptor antibody-negative patients with Graves' hyperthyroidism.
Zuhur SS; Bilen O; Aggul H; Topcu B; Celikkol A; Elbuken G
Endokrynol Pol; 2021; 72(1):14-21. PubMed ID: 32944926
[TBL] [Abstract][Full Text] [Related]
3. Decreased serum level of IL-7 in patients with active Graves' disease.
Motylewska E; Nieć M; Siejka A; Komorowski J; Ławnicka H; Świętosławski J; Stępień H
Cytokine; 2015 Oct; 75(2):373-9. PubMed ID: 26113403
[TBL] [Abstract][Full Text] [Related]
4. Clinical evaluation of an automated TSI bridge immunoassay in the diagnosis of Graves' disease and its relationship to the degree of hyperthyroidism.
Liu T; Zhang X; Long L; Zhou L; Chen J; Li M; Gao Y; Zhou X; Han X; Ji L
BMC Endocr Disord; 2022 Aug; 22(1):218. PubMed ID: 36045442
[TBL] [Abstract][Full Text] [Related]
5. Thyroid-stimulating antibody is related to Graves' ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease.
Noh JY; Hamada N; Inoue Y; Abe Y; Ito K; Ito K
Thyroid; 2000 Sep; 10(9):809-13. PubMed ID: 11041459
[TBL] [Abstract][Full Text] [Related]
6. Persistent increase in bone turnover in Graves' patients with subclinical hyperthyroidism.
Kumeda Y; Inaba M; Tahara H; Kurioka Y; Ishikawa T; Morii H; Nishizawa Y
J Clin Endocrinol Metab; 2000 Nov; 85(11):4157-61. PubMed ID: 11095447
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic testing for Graves' or non-Graves' hyperthyroidism: A comparison of two thyrotropin receptor antibody immunoassays with thyroid scintigraphy and ultrasonography.
Scappaticcio L; Trimboli P; Keller F; Imperiali M; Piccardo A; Giovanella L
Clin Endocrinol (Oxf); 2020 Feb; 92(2):169-178. PubMed ID: 31742747
[TBL] [Abstract][Full Text] [Related]
8. TSH-receptor antibody measurement for differentiation of hyperthyroidism into Graves' disease and multinodular toxic goitre: a comparison of two competitive binding assays.
Pedersen IB; Knudsen N; Perrild H; Ovesen L; Laurberg P
Clin Endocrinol (Oxf); 2001 Sep; 55(3):381-90. PubMed ID: 11589682
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of thyroglobulin antibodies and thyroid peroxidase antibodies in Graves' disease: a cross-sectional study.
Katahira M; Tsunekawa T; Mizoguchi A; Yamaguchi M; Tsuru K; Takashima H; Terada R
Hormones (Athens); 2023 Jun; 22(2):253-261. PubMed ID: 36811756
[TBL] [Abstract][Full Text] [Related]
10. Graves' ophthalmopathy in the absence of elevated free thyroxine and triiodothyronine levels: prevalence, natural history, and thyrotropin receptor antibody levels.
Khoo DH; Eng PH; Ho SC; Tai ES; Morgenthaler NG; Seah LL; Fong KS; Chee SP; Choo CT; Aw SE
Thyroid; 2000 Dec; 10(12):1093-100. PubMed ID: 11201855
[TBL] [Abstract][Full Text] [Related]
11. Sensitive thyrotropin and thyrotropin-receptor antibody determinations one month after discontinuation of antithyroid drug treatment as predictors of relapse in Graves' disease.
Quadbeck B; Hoermann R; Roggenbuck U; Hahn S; Mann K; Janssen OE;
Thyroid; 2005 Sep; 15(9):1047-54. PubMed ID: 16187913
[TBL] [Abstract][Full Text] [Related]
12. fT3:fT4 ratio in Graves' disease - correlation with TRAb level, goiter size and age of onset.
Minasyan M; Dulęba A; Smalarz A; Stręk M; Bryniarski P; Przybylik-Mazurek E; Hubalewska-Dydejczyk A
Folia Med Cracov; 2020 Sep; 60(2):15-27. PubMed ID: 33252592
[TBL] [Abstract][Full Text] [Related]
13. Endothelial dysfunction in children with newly diagnosed Graves' disease.
Gamal Y; Badawy A; Ali AM; Farghaly HS; Metwalley KA; Gaber N; Allam MT; Farouk Y
Eur J Pediatr; 2023 Jun; 182(6):2793-2800. PubMed ID: 37022495
[TBL] [Abstract][Full Text] [Related]
14. Free triiodothyronine to free thyroxine ratio in the differential diagnosis of thyrotoxicosis and hyperthyroidism: A retrospective study.
Tura Bahadır Ç; Yılmaz M; Kılıçkan E
Int J Clin Pract; 2021 May; 75(5):e14003. PubMed ID: 33403716
[TBL] [Abstract][Full Text] [Related]
15. Studies of thyroid function and immune parameters in patients with hyperthyroid Graves' disease in remission.
Murakami M; Koizumi Y; Aizawa T; Yamada T; Takahashi Y; Watanabe T; Kamoi K
J Clin Endocrinol Metab; 1988 Jan; 66(1):103-8. PubMed ID: 3121661
[TBL] [Abstract][Full Text] [Related]
16. Inactivated SARS-CoV-2 vaccination does not disturb the clinical course of Graves' disease: An observational cohort study.
Xu S; Yu H; Cheng X; Wu J; Bao J; Zhang L
Vaccine; 2023 Aug; 41(38):5648-5654. PubMed ID: 37544826
[TBL] [Abstract][Full Text] [Related]
17. The serum concentration and activity of DPP4 is positively related with the severity of hyperthyroidism in patients with Graves' disease.
Chang X; Ding X; Wang J; Cai Q; Wang G; Liu J
Ann Med; 2023 Dec; 55(1):2226910. PubMed ID: 37350750
[TBL] [Abstract][Full Text] [Related]
18. Low Vitamin D Status is Associated with Increased Thyrotropin-Receptor Antibody Titer in Graves Disease.
Zhang H; Liang L; Xie Z
Endocr Pract; 2015 Mar; 21(3):258-63. PubMed ID: 25370319
[TBL] [Abstract][Full Text] [Related]
19. Serum thyrotropin receptor antibodies concentrations in patients with Graves' disease before, at the end of methimazole treatment, and after drug withdrawal: evidence that the activity of thyrotropin receptor antibody and/or thyroid response modify during the observation period.
Carella C; Mazziotti G; Sorvillo F; Piscopo M; Cioffi M; Pilla P; Nersita R; Iorio S; Amato G; Braverman LE; Roti E
Thyroid; 2006 Mar; 16(3):295-302. PubMed ID: 16571093
[TBL] [Abstract][Full Text] [Related]
20. Immunoglobulins of untreated Graves' patients with or without thyrotropin receptor antibody (determined by porcine thyrocytes) universally elicit potent thyroid hormone-releasing activity in cultured human thyroid follicles.
Sato K; Yamazaki K; Yamada E; Kanaji Y; Miura M; Obara T
Thyroid; 1999 Oct; 9(10):979-88. PubMed ID: 10560951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]